483
RK Pharma Inc.FDA 483 - RK Pharma Inc. - August 28, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Rx Pharma Inc., a drug product manufacturer in Pearl River, NY, revealed significant deficiencies in its quality control unit and manufacturing processes. The firm failed to adequately follow written procedures for process validation, exhibited issues with batch record documentation, and did not properly test components for purity, strength, and quality. These findings indicate a lack of adherence to Good Manufacturing Practices.
- Office
- New York District Office
- Person
Open in Dashboard
ID · eb5c7d5d-c81f-45ea-be5e-0b359bb7dde1